A record 40 mn kids missed measles vaccine dose last year: WHO, US CDC

the WHO and the CDC said millions of children were now susceptible to measles, among the world's most contagious diseases

Measles, vaccine, vaccination
Measles is mostly spread through direct contact or in the air and causes symptoms including fever, muscle pain and a skin rash on the face and upper neck.
AP London
2 min read Last Updated : Nov 24 2022 | 7:50 AM IST

The World Health Organisation and the U.S. Centers for Disease Control and Prevention say measles immunisation has dropped significantly since the coronavirus pandemic began, resulting in a record high of nearly 40 million children missing a vaccine dose last year.

In a report issued Wednesday, the WHO and the CDC said millions of children were now susceptible to measles, among the world's most contagious diseases.

In 2021, officials said there were about 9 million measles infections and 128,000 deaths worldwide.

The WHO and CDC said continued drops in vaccination, weak disease surveillance and delayed response plans due to COVID-19, in addition to ongoing outbreaks in more than 20 countries, mean that measles is an imminent threat in every region of the world.

Scientists estimate that at least 95% of a population needs to be immunised to protect against epidemics; the WHO and the CDC reported that only about 81% of children receive their first dose of measles vaccine while 71% get their second dose, marking the lowest global coverage rates of the first measles dose since 2008.

The record number of children under-immunised and susceptible to measles shows the profound damage immunisation systems have sustained during the COVID-19 pandemic, CDC director Dr. Rochelle Walensky said in a statement.

Measles is mostly spread through direct contact or in the air and causes symptoms including fever, muscle pain and a skin rash on the face and upper neck.

Most measles-related deaths are caused by complications including swelling of the brain and dehydration.

The WHO says serious complications are most serious in children under five and adults over 30.

More than 95% of measles deaths occur in developing countries, mostly in Africa and Asia.

There is no specific treatment for measles, but the two-dose vaccine against it is about 97% effective in preventing severe illness and death.

In July, the U.N. said 25 million children have missed out on routine immunisations against diseases including diphtheria, largely because the coronavirus disrupted routine health services or triggered vaccine misinformation.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :measles vaccinationmeaslesWHO

First Published: Nov 24 2022 | 7:50 AM IST

Next Story